IDEXX Laboratories/$IDXX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About IDEXX Laboratories
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
Ticker
$IDXX
Sector
Primary listing
Employees
11,000
Headquarters
Website
IDXX Metrics
BasicAdvanced
$55B
54.84
$12.60
1.69
-
Price and volume
Market cap
$55B
Beta
1.69
52-week high
$769.98
52-week low
$356.14
Average daily volume
484K
Financial strength
Current ratio
1.18
Quick ratio
0.619
Long term debt to equity
30.83
Total debt to equity
62.761
Interest coverage (TTM)
28.52%
Profitability
EBITDA (TTM)
1,437.28
Gross margin (TTM)
61.72%
Net profit margin (TTM)
24.65%
Operating margin (TTM)
31.13%
Effective tax rate (TTM)
19.33%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
25.21%
Return on equity (TTM)
64.63%
Valuation
Price to earnings (TTM)
54.842
Price to revenue (TTM)
13.417
Price to book
35.41
Price to tangible book (TTM)
35.41
Price to free cash flow (TTM)
59.471
Free cash flow yield (TTM)
1.68%
Free cash flow per share (TTM)
11.62
Growth
Revenue change (TTM)
8.39%
Earnings per share change (TTM)
21.65%
3-year revenue growth (CAGR)
7.66%
10-year revenue growth (CAGR)
10.37%
3-year earnings per share growth (CAGR)
17.05%
10-year earnings per share growth (CAGR)
21.25%
What the Analysts think about IDXX
Analyst ratings (Buy, Hold, Sell) for IDEXX Laboratories stock.
IDXX Financial Performance
Revenues and expenses
IDXX Earnings Performance
Company profitability
IDXX News
AllArticlesVideos
Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus
Business Wire·1 week ago
IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results
Business Wire·2 weeks ago
Final Trades: Palo Alto Networks, Capital One, Idexx Labs and the XLB
CNBC Television·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for IDEXX Laboratories stock?
IDEXX Laboratories (IDXX) has a market cap of $55B as of January 24, 2026.
What is the P/E ratio for IDEXX Laboratories stock?
The price to earnings (P/E) ratio for IDEXX Laboratories (IDXX) stock is 54.84 as of January 24, 2026.
Does IDEXX Laboratories stock pay dividends?
No, IDEXX Laboratories (IDXX) stock does not pay dividends to its shareholders as of January 24, 2026.
When is the next IDEXX Laboratories dividend payment date?
IDEXX Laboratories (IDXX) stock does not pay dividends to its shareholders.
What is the beta indicator for IDEXX Laboratories?
IDEXX Laboratories (IDXX) has a beta rating of 1.69. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.